Metformin and Canagliflozin

Therapeutic indications

Metformin and Canagliflozin is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

Canagliflozin/metformin combination is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise:

  • in patients insufficiently controlled on their maximally tolerated doses of metformin alone
  • in combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with metformin and these medicinal products
  • in patients already being treated with the combination of canagliflozin and metformin as separate tablets.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Metformin and Canagliflozin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: VOKANAMET Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈